Adapting to the brave new world of lung cancer treatment.
作者： Mary C Pinder-Schenck , Scott J Antonia
DOI:
关键词:
摘要: If we are to provide new options for the large numbers of NSCLC patients with no actionable mutation, must focus on identifying mutations through tissue acquisition. In meantime, these ideal candidates number available immunotherapy trials.
cancernetwork.com参考文章(8)
Edward S Kim, Roy S Herbst, Ignacio I Wistuba, J Jack Lee, George R Blumenschein Jr, Anne Tsao, David J Stewart, Marshall E Hicks, Jeremy Erasmus Jr, Sanjay Gupta, Christine M Alden, Suyu Liu, Ximing Tang, Fadlo R Khuri, Hai T Tran, Bruce E Johnson, John V Heymach, Li Mao, Frank Fossella, Merrill S Kies, Vassiliki Papadimitrakopoulou, Suzanne E Davis, Scott M Lippman, Waun K Hong, None, The BATTLE Trial: Personalizing Therapy for Lung Cancer Cancer Discovery. ,vol. 1, pp. 44- 53 ,(2011) , 10.1158/2159-8274.CD-10-0010
Martin Reck, Andreas Hermes, Eng-Huat Tan, Enriqueta Felip, Barbara Klughammer, José Baselga, Tissue sampling in lung cancer: A review in light of the MERIT experience Lung Cancer. ,vol. 74, pp. 1- 6 ,(2011) , 10.1016/J.LUNGCAN.2011.05.002
Chang-Qi Zhu, Gilda da Cunha Santos, Keyue Ding, Akira Sakurada, Jean-Claude Cutz, Ni Liu, Tong Zhang, Paula Marrano, Marlo Whitehead, Jeremy A. Squire, Suzanne Kamel-Reid, Lesley Seymour, Frances A. Shepherd, Ming-Sound Tsao, Role ofKRASandEGFRAs Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Journal of Clinical Oncology. ,vol. 26, pp. 4268- 4275 ,(2008) , 10.1200/JCO.2007.14.8924
Fred R. Hirsch, Marileila Varella-Garcia, Paul A. Bunn, Wilbur A. Franklin, Rafal Dziadziuszko, Nick Thatcher, Alex Chang, Purvish Parikh, José Rodrigues Pereira, Tudor Ciuleanu, Joachim von Pawel, Claire Watkins, Angela Flannery, Gillian Ellison, Emma Donald, Lucy Knight, Dinah Parums, Nicholas Botwood, Brian Holloway, Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer Journal of Clinical Oncology. ,vol. 24, pp. 5034- 5042 ,(2006) , 10.1200/JCO.2006.06.3958
Edward S Kim, Vera Hirsh, Tony Mok, Mark A Socinski, Radj Gervais, Yi-Long Wu, Long-Yun Li, Claire L Watkins, Mark V Sellers, Elizabeth S Lowe, Yan Sun, Mei-Lin Liao, Kell Østerlind, Martin Reck, Alison A Armour, Frances A Shepherd, Scott M Lippman, Jean-Yves Douillard, Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial The Lancet. ,vol. 372, pp. 1809- 1818 ,(2008) , 10.1016/S0140-6736(08)61758-4
David A. Eberhard, Bruce E. Johnson, Lukas C. Amler, Audrey D. Goddard, Sherry L. Heldens, Roy S. Herbst, William L. Ince, Pasi A. Jänne, Thomas Januario, David H. Johnson, Pam Klein, Vincent A. Miller, Michael A. Ostland, David A. Ramies, Dragan Sebisanovic, Jeremy A. Stinson, Yu R. Zhang, Somasekar Seshagiri, Kenneth J. Hillan, Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib Journal of Clinical Oncology. ,vol. 23, pp. 5900- 5909 ,(2005) , 10.1200/JCO.2005.02.857
Tony S. Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose, Yutaka Nishiwaki, Yuichiro Ohe, Jin-Ji Yang, Busyamas Chewaskulyong, Haiyi Jiang, Emma L. Duffield, Claire L. Watkins, Alison A. Armour, Masahiro Fukuoka, Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma The New England Journal of Medicine. ,vol. 361, pp. 947- 957 ,(2009) , 10.1056/NEJMOA0810699
Primo N. Lara, Roger Higdon, Nelson Lim, Karen Kwan, Michael Tanaka, Derick H.M. Lau, Ted Wun, Jeanna Welborn, Frederick J. Meyers, Scott Christensen, Robert O’Donnell, Carol Richman, Sidney A. Scudder, Joseph Tuscano, David R. Gandara, Kit S. Lam, Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment Journal of Clinical Oncology. ,vol. 19, pp. 1728- 1733 ,(2001) , 10.1200/JCO.2001.19.6.1728